| Literature DB >> 35210474 |
Wenqiao Ding1,2, Xueying Zhang1, Xiaoyu Yin1, Qing Zhang1, Ying Wang1, Changhong Guo3, Ying Chen4,5.
Abstract
In this study, the single-cell eukaryotic model organism Tetrahymena thermophila was used as an experimental material to reveal the anti-aging mechanism of Ganoderma lucidum aqueous extract. After treatment with the G. lucidum aqueous extract, the logarithmic phase was extended, and the maximum density of T. thermophila increased to 5.5 × 104 cells/mL. The aqueous extract was more effective than the main active monomers of G. lucidum. The membrane integrity in the cell including mitochondria and nucleus appeared improvement after treatment with the G. lucidum aqueous extract, which observed by ammonia silver staining and transmission electron microscopy. Gene Ontology (GO) functional enrichment of the differentially expressed genes in transcriptome showed that the G. lucidum aqueous extract promoted the biological metabolic process of membrane components. According to Kyoto Encyclopedia of Genes and Genomes (KEGG), the glutathione metabolism process was enhanced in both growth phases. Protein-protein interaction (PPI) network analysis illustrated that phospholipid hydroperoxide glutathione peroxidase (PHGPx) played a key role in the anti-aging mechanism. The results suggested that G. lucidum aqueous extract improved the GPX activity as well as reduced the malondialdehyde content and cell damage. More importantly, the expression of PHGPx was promoted to reduce the oxidation degree of the membrane lipids and enhance the integrity of the membrane to achieve anti-aging effects.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35210474 PMCID: PMC8873301 DOI: 10.1038/s41598-022-06985-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Effects of G. lucidum aqueous extract and G. lucidum monomers on the growth of T. thermophila.
Figure 2Effect of G. lucidum aqueous extract on ROS, MDA and ·OH in T. thermophila. (a–d, ×100). (a) ROS fluorescence in the logarithmic phase of the control group. (b) ROS fluorescence showed in the control group during the decline phase. (c) ROS fluorescence in the logarithmic phase of the experimental group applicated with G. lucidum aqueous extract. (d) ROS fluorescence in the decline phase of the experimental group applicated with G. lucidum aqueous extract. (e) The accumulation of MDA volume and ·OH in logarithmic and decline phases in the control and experimental groups. Symbols: CK1, the logarithmic phase of the control group. CK2, the decline phases of the control group. G1, the logarithmic phase of the experience group. G2, the decline phase of the experience group. *p < 0.05, **p < 0.001, ns, not significant difference.
Figure 3GO enrichment analysis and KEGG pathway enrichment. (a) GO enrichment analysis in logarithmic phase and decline phase. (b) The proportion of up or down regulated genes in BP, MF and CC in logarithmic phase. (c) The proportion of up or down regulated genes in BP, MF and CC in decline phase. (d) KEGG enrichment in logarithmic phase. (e) KEGG enrichment of different genes in decline phase.
Figure 4PPI mapping of DEGs in the glutathione-metabolism pathway. (a) Logarithmic phase. (b) Decline phase.
Figure 5The activity of PHGPx in the logarithmic and decline phases. (a) The NADPH/ NADP+ ratio of T. tetrahymena in the two phases between control and experimental groups (b) The GSH/GSSH ratio of T. tetrahymena in the two phases between control and experimental groups Symbols: *p < 0.05, **p < 0.001, ns, not significant difference.
Figure 6The observation of micromorphology and ultrastructure in control cells and experimental cells. (a) The ammonia silver staining of control group in the logarithmic phase. (b) The TEM observation of control group in the logarithmic phase. Mitochondria were circled by a red coil. (c) The ammonia silver staining of control group in the decline phase. (d) The TEM observation of control group in the decline phase. Mitochondria were circled by a red coil. (e) The ammonia silver staining of experimental group in the logarithmic phase. (f) The TEM observation of experimental group in the logarithmic phase. Mitochondria were circled by a blue coil. (g) The ammonia silver staining of experimental group in the decline phase. (h) The TEM observation of experimental group in the decline phase. Mitochondria were circled by a blue coil.
Anti-aging researches of G. lucidum aqueous extract and main active monomers.
| Extraction | Previous work |
|---|---|
| Contains several bioactive phytochemicals such as polysaccharides, nucleosides, alkaloids, coumarin, ergosterols, ganoderic acids, lactones, mannitol, organic germanium, triterpenoids, unsaturated fatty acids[ | |
| Increase radical scavenging activity and ferric reducing antioxidant power[ | |
| Adjuvant treatment of neurological diseases[ | |
| Antioxidant, immunomodulatory, antineurodegenerative and antidiabetic activities[ | |
| Ganoderma acid | Interact with membrane receptors mainly, receptor tyrosine kinase (RTKs). Ganoderic acid interacts and modulates the signaling network in IR, IGFR-1, IGFR-2, VEGFR-1, VEFGR-2, and EGFR in cancer signaling pathways. It primarily targets NF-κB, RAS-MAPK, PI3K/Akt/mTOR, and cell cycle resulting in apoptosis[ |
| Ganoderma aldehyde | Inhibitted the growth of liver cancer PLC/PRF/5 and KB cells[ |
| To ensure cell viability, membrane fluidity, membrane binding enzyme activity, membrane integrity, and cellular material transport plays an important role[ |
Figure 7Schematic diagram of anti-aging mechanism of G. lucidum aqueous extract based on PHGPx.